Technical Analysis for QGEN - Qiagen N.V.

Grade Last Price % Change Price Change
grade D 34.04 -0.26% -0.09
QGEN closed down 0.26 percent on Wednesday, September 18, 2019, on 57 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical QGEN trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
20 DMA Resistance Bearish -0.26%
Bollinger Band Squeeze Range Contraction -0.26%
Bollinger Band Squeeze Range Contraction 0.09%
NR7 Range Contraction 0.09%
Lower Bollinger Band Walk Weakness 0.09%
Inside Day Range Contraction 0.09%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%

Older signals for QGEN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
QIAGEN N.V., through its subsidiaries, provides sample and assay technologies worldwide. It offers approximately 500 core consumable products, such as sample and assay kits, and automated instrumentation systems that empower customers to transform raw biological samples into molecular information. The company's consumable products are used for plasmid deoxyribonucleic acid (DNA) purification, and ribonucleic acid purification and stabilization; genomic and viral nucleic acid purification; nucleic acid transfection; polymerase chain reaction (PCR) amplification; reverse transcription; DNA cleanup after PCR and sequencing; and DNA cloning and protein purification. The company sells the digene HC2 HPV Test, a signal-amplified test for high-risk strains of the human papillomavirus. It also offers co-development services for companion diagnostics, technology licensing and patent sales services, and custom services, including whole genome amplification, DNA sequencing, and non-cGMP DNA production on a contract basis. The company's instrumentation systems automate the use of sample and assay technologies into solutions for a range of laboratory needs enabling customers to perform nucleic acid sample preparation, assay setup, target detection, and other laboratory tasks. Its automated systems include QIAsymphony, a modular system; Rotor-Gene Q, a rotary real-time PCR cycler system; PyroMark, a high-resolution detection platform based upon the Pyrosequencing technology; QIAcube, a sample processing instrument; QIAxcel for nucleic acid separation in low- to high-throughput laboratories; and ESE-Quant Tube Scanners, an optical measurement device. The company serves customer classes, including molecular diagnostics laboratories; applied testing customers in fields, such as forensics, veterinary diagnostics, and food safety; pharmaceutical research and development groups, and academic researchers. QIAGEN N.V. was founded in 1986 and is headquartered in Venlo, the Netherlands.
Chemistry Biotechnology Biology Nature Molecular Biology Consumable Products Molecular Diagnostics Food Safety Laboratory Techniques Polymerase Chain Reaction Dna Sequencing HPV Instrumentation Systems Pharmaceutical Research Qiagen Cloning Real Time Polymerase Chain Reaction Technology Licensing
Is QGEN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 41.55
52 Week Low 31.71
Average Volume 801,008
200-Day Moving Average 37.6027
50-Day Moving Average 36.2814
20-Day Moving Average 34.216
10-Day Moving Average 33.955
Average True Range 0.5348
ADX 37.27
+DI 16.0228
-DI 29.3233
Chandelier Exit (Long, 3 ATRs ) 33.5056
Chandelier Exit (Short, 3 ATRs ) 34.2964
Upper Bollinger Band 34.9015
Lower Bollinger Band 33.5305
Percent B (%b) 0.37
BandWidth 4.006897
MACD Line -0.586
MACD Signal Line -0.7311
MACD Histogram 0.1451
Fundamentals Value
Market Cap 7.77 Billion
Num Shares 228 Million
EPS 0.33
Price-to-Earnings (P/E) Ratio 103.15
Price-to-Sales 5.65
Price-to-Book 3.07
PEG Ratio 2.07
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 34.67
Resistance 3 (R3) 34.68 34.47 34.57
Resistance 2 (R2) 34.47 34.31 34.47 34.53
Resistance 1 (R1) 34.26 34.21 34.16 34.25 34.49
Pivot Point 34.05 34.05 34.00 34.05 34.05
Support 1 (S1) 33.84 33.89 33.74 33.83 33.59
Support 2 (S2) 33.63 33.79 33.63 33.55
Support 3 (S3) 33.42 33.63 33.52
Support 4 (S4) 33.41